The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway

Abstract Background Acute lung injury is an important factor that leads to the death of patients with pneumonia. Previous studies have shown that nicotinamide (NAM) plays a role in reducing cell damage, so this study explored the mechanism by which NAM functions in acute lung injury. Methods We expl...

Full description

Bibliographic Details
Main Authors: Qun Zhang, Junyao Li, Haixia Zhong, Yanling Xu
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-021-00376-2
_version_ 1818882175869648896
author Qun Zhang
Junyao Li
Haixia Zhong
Yanling Xu
author_facet Qun Zhang
Junyao Li
Haixia Zhong
Yanling Xu
author_sort Qun Zhang
collection DOAJ
description Abstract Background Acute lung injury is an important factor that leads to the death of patients with pneumonia. Previous studies have shown that nicotinamide (NAM) plays a role in reducing cell damage, so this study explored the mechanism by which NAM functions in acute lung injury. Methods We explored the mechanism by which NAM affects acute lung injury in vivo and in vitro by qRT-PCR, western blotting and ELISA. Results The results showed that NAM could significantly reduce lung injury and proinflammatory mediator accumulation. Further mechanistic studies showed that NAM could significantly inhibit the MAPK and AKT/NF-κB signaling pathways. Conclusion These results suggested that NAM may reduce the release of proinflammatory mediators by inhibiting the MAPK and AKT/NF-κB signaling pathways and ultimately alleviate lung injury.
first_indexed 2024-12-19T15:13:35Z
format Article
id doaj.art-b5be22cc82fb4b85b5097743167dc745
institution Directory Open Access Journal
issn 1076-1551
1528-3658
language English
last_indexed 2024-12-19T15:13:35Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj.art-b5be22cc82fb4b85b5097743167dc7452022-12-21T20:16:13ZengBMCMolecular Medicine1076-15511528-36582021-09-0127111110.1186/s10020-021-00376-2The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathwayQun Zhang0Junyao Li1Haixia Zhong2Yanling Xu3Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin UniversityDepartment of Respiratory and Critical Care Medicine, The Second Hospital of Jilin UniversityDepartment of Respiration, General Hospital of Jilin Tonghua Mining Co., LtdDepartment of Respiratory and Critical Care Medicine, The Second Hospital of Jilin UniversityAbstract Background Acute lung injury is an important factor that leads to the death of patients with pneumonia. Previous studies have shown that nicotinamide (NAM) plays a role in reducing cell damage, so this study explored the mechanism by which NAM functions in acute lung injury. Methods We explored the mechanism by which NAM affects acute lung injury in vivo and in vitro by qRT-PCR, western blotting and ELISA. Results The results showed that NAM could significantly reduce lung injury and proinflammatory mediator accumulation. Further mechanistic studies showed that NAM could significantly inhibit the MAPK and AKT/NF-κB signaling pathways. Conclusion These results suggested that NAM may reduce the release of proinflammatory mediators by inhibiting the MAPK and AKT/NF-κB signaling pathways and ultimately alleviate lung injury.https://doi.org/10.1186/s10020-021-00376-2Acute lung injuryNicotinamideMAPKAKT/NF-κB
spellingShingle Qun Zhang
Junyao Li
Haixia Zhong
Yanling Xu
The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
Molecular Medicine
Acute lung injury
Nicotinamide
MAPK
AKT/NF-κB
title The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
title_full The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
title_fullStr The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
title_full_unstemmed The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
title_short The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-κB signal pathway
title_sort mechanism of nicotinamide on reducing acute lung injury by inhibiting mapk and nf κb signal pathway
topic Acute lung injury
Nicotinamide
MAPK
AKT/NF-κB
url https://doi.org/10.1186/s10020-021-00376-2
work_keys_str_mv AT qunzhang themechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT junyaoli themechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT haixiazhong themechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT yanlingxu themechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT qunzhang mechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT junyaoli mechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT haixiazhong mechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway
AT yanlingxu mechanismofnicotinamideonreducingacutelunginjurybyinhibitingmapkandnfkbsignalpathway